| NCT05100329 |
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer |
View |
| NCT01486329 |
VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer |
View |
| NCT04101929 |
Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen |
View |
| NCT06409429 |
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer |
View |
| NCT02125929 |
Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms |
View |
| NCT05573776 |
A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy |
View |
| NCT06893276 |
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients |
View |
| NCT06206876 |
FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma |
View |
| NCT00313560 |
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) |
View |
| NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
View |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
View |
| NCT06119776 |
Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study |
View |
| NCT04157127 |
Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma |
View |
| NCT00255827 |
Vaccine Treatment for Surgically Resected Pancreatic Cancer |
View |
| NCT05627427 |
Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy |
View |
| NCT04892927 |
NCI SBIR Contract for Patient Navigation Tool Prototype Development |
View |
| NCT01438476 |
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas |
View |
| NCT02172976 |
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma |
View |
| NCT00908960 |
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles |
View |
| NCT04524260 |
The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients |
View |
| NCT00383760 |
Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients |
View |
| NCT00369460 |
Changes in Muscle Tissue in Patients With Pancreatic Cancer |
View |
| NCT06134960 |
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor |
View |
| NCT02230176 |
Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II |
View |
| NCT05477576 |
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy |
View |
